Holen Sie sich die Stockscreener-App
642.25
1.47%
-9.55
Handel nachbörslich:
641.80
-0.45
-0.07%
Schlusskurs vom Vortag:
$651.80
Offen:
$657.46
24-Stunden-Volumen:
809.66K
Relative Volume:
0.77
Marktkapitalisierung:
$66.90B
Einnahmen:
$14.25B
Nettoeinkommen (Verlust:
$4.58B
KGV:
15.38
EPS:
41.7701
Netto-Cashflow:
$3.88B
1W Leistung:
+9.73%
1M Leistung:
+7.04%
6M Leistung:
+6.05%
1J Leistung:
-23.87%
1-Tages-Spanne:
$627.50
$657.46
1-Wochen-Bereich:
$605.03
$664.00
52-Wochen-Spanne:
$476.49
$852.01
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
Firmenname
Regeneron Pharmaceuticals Inc
Sektor
Branche
Telefon
(914) 847-7000
Adresse
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Vergleichen Sie REGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-14 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-30 | Herabstufung | Argus | Buy → Hold |
| 2025-05-30 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-02-05 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-09-24 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | Eingeleitet | Bernstein | Outperform |
| 2024-01-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | Bestätigt | Oppenheimer | Perform |
| 2023-06-28 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | Hochstufung | Jefferies | Hold → Buy |
| 2023-03-23 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2023-01-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-10-26 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-09-09 | Hochstufung | Jefferies | Underperform → Hold |
| 2022-09-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-01-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-01-03 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-12-07 | Fortgesetzt | Cowen | Market Perform |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Fortgesetzt | BMO Capital Markets | Outperform |
| 2021-11-05 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-01-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-01-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-10-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-09 | Hochstufung | SunTrust | Hold → Buy |
| 2020-05-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-17 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-04-08 | Eingeleitet | The Benchmark Company | Hold |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-26 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-11 | Hochstufung | Argus | Hold → Buy |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-16 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-12-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | Eingeleitet | SunTrust | Hold |
| 2019-11-07 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Hochstufung | Guggenheim | Neutral → Buy |
Alle ansehen
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
Regeneron Announces Investor Conference Presentations - Yahoo! Finance Singapore
Regeneron to Sell Former Avon Property in Suffern - Rockland News
Can Regeneron Pharmaceuticals Inc. stock weather global recessionWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
Can a trend reversal in Regeneron Pharmaceuticals Inc. lead to recoveryQuarterly Market Review & Verified Entry Point Signals - newser.com
2 Beaten-Down Stocks That Could Be About to Rally - The Globe and Mail
How Regeneron Pharmaceuticals Inc. stock responds to policy changesDollar Strength & Fast Entry High Yield Stock Tips - newser.com
Intellectus Partners LLC Has $1.39 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What does recent volatility data suggest for Regeneron Pharmaceuticals Inc.Stop Loss & Weekly Top Gainers Trade List - newser.com
Cambiar Investors LLC Buys 12,160 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Triglav Investments D.O.O. Purchases Shares of 2,515 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Why Regeneron Pharmaceuticals Inc. stock is considered a top pick2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Lifeworks Advisors LLC - MarketBeat
Harel Insurance Investments & Financial Services Ltd. Increases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Diabetic Retinopathy Market 2025 | Industry Developments, - openPR.com
Published on: 2025-11-03 02:40:17 - newser.com
Will earnings trigger a reversal in Regeneron Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Heatmap analysis for Regeneron Pharmaceuticals Inc. and competitorsWeekly Trade Report & Risk Controlled Swing Alerts - newser.com
Antibody Cocktails Market See Incredible Growth 2025-2032 - openPR.com
Using fundamentals and technicals on Regeneron Pharmaceuticals Inc.Market Movement Recap & Long-Term Investment Growth Plans - newser.com
Published on: 2025-11-02 22:34:33 - newser.com
Is Regeneron Pharmaceuticals Inc. stock positioned for digital transformationWeekly Trend Report & Low Risk High Win Rate Stock Picks - newser.com
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130% - The Motley Fool
News impact scoring models applied to Regeneron Pharmaceuticals Inc.Quarterly Trade Report & Growth Focused Entry Reports - newser.com
What data driven models say about Regeneron Pharmaceuticals Inc.’s futureMarket Movement Recap & Real-Time Buy Zone Alerts - newser.com
AMG National Trust Bank Buys Shares of 5,969 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Atria Investments Inc Purchases 1,442 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Flagship Harbor Advisors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Arkadios Wealth Advisors Has $1.07 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Oppenheimer Asset Management Inc. Purchases 643 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded at Wall Street Zen - MarketBeat
How currency fluctuations impact Regeneron Pharmaceuticals Inc. stockForecast Cut & Technical Pattern Recognition Alerts - newser.com
Pharmaceutical Stocks To Keep An Eye OnOctober 28th - MarketBeat
Christine Poon Sells 6,500 Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) Stock - MarketBeat
Combining price and volume data for Regeneron Pharmaceuticals Inc.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Is Regeneron Pharmaceuticals Inc. trending in predictive chart modelsMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Why Regeneron Pharmaceuticals Inc. (RGO) stock is listed among top recommendationsJuly 2025 Sentiment & Stock Market Timing Techniques - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Pinnacle Associates Ltd. - MarketBeat
Amalgamated Bank Sells 557 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Published on: 2025-11-01 03:40:36 - newser.com
Why millennials buy Regeneron Pharmaceuticals Inc. (RGO) stockMarket Trend Report & Free Technical Confirmation Trade Alerts - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Stake Lessened by Brighton Jones LLC - MarketBeat
Regeneron Pharmaceuticals (REGN): Evaluating Valuation as Momentum Builds After Recent Share Price Gains - simplywall.st
Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance
Regeneron, the False Claims Act, and a New Era in Government Enforcement - The National Law Review
Rothschild & Co Redburn Adjusts Price Target on Regeneron Pharmaceuticals to $910 From $900 - MarketScreener
Dupixent wins 2025 Prix Galien USA Best Biotechnology Product award - PharmaLive
UNIVEST FINANCIAL Corp Boosts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer - BioSpace
Libtayo® (cemiplimab for injection) Now Reimbursed in Seven Provinces for Advanced Non-Small Cell Lung Cancer and Locally Advanced Basal Cell Carcinoma - BioSpace
Retirement Systems of Alabama Has $67.81 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals' Dupixent® Awarded "Best Biotechnology Product" by Galien Foundation for 2025 - Quiver Quantitative
Finanzdaten der Regeneron Pharmaceuticals Inc-Aktie (REGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.82%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):